Chronic stress speeds colorectal cancer's spread dramatically by disrupting gut microbiota -- the delicate balance of good ...

Researchers at Massachusetts General Hospital have discovered that meeting the weekly recommended physical activity levels, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration has approved HYMPAVZI (marstacimab-hncq) for routine ...

The cost of healthcare in the U.S. remains outrageously high, despite massive government subsidies. The system is designed to ...

The FDA approved Pfizer’s Hympavzi (marstacimab-hncq) to prevent or reduce the frequency of bleeding episodes in patients age ...

Recent health developments include HIV infections from organ transplants in Brazil, Sanofi's potential sale of a stake in its ...

The FDA approved marstacimab (Hympavzi) for routine prophylaxis to prevent or reduce bleeding episodes in adults and ...

The monoclonal antibody is the first non-factor, once-weekly treatment approved in the United States for hemophilia B.

Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

Here are some of the major companies whose stocks moved on the week’s news.